pyrvinium has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakoshi, M; Saiki, K; Sato, TN; Urayama, K | 1 |
| Alfaro, MP; Atkinson, J; Lee, E; Saraswati, S; Thorne, CA; Young, PP | 1 |
2 other study(ies) available for pyrvinium and Cardiovascular Stroke
| Article | Year |
|---|---|
An anthelmintic drug, pyrvinium pamoate, thwarts fibrosis and ameliorates myocardial contractile dysfunction in a mouse model of myocardial infarction.
Topics: Animals; Anthelmintics; Cell Survival; Disease Models, Animal; Fibroblasts; Fibrosis; Male; Mice; Muscle Contraction; Myocardial Infarction; Myocardium; Pyrvinium Compounds | 2013 |
Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.
Topics: Adaptor Proteins, Signal Transducing; Animals; Axin Protein; beta Catenin; Casein Kinase Ialpha; Cell Proliferation; Chemokines; Enzyme Activation; Gene Expression; Heart; HEK293 Cells; Humans; Immunoblotting; Intercellular Signaling Peptides and Proteins; Mice; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-myc; Pyrvinium Compounds; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Ventricular Remodeling; Wnt Proteins; Wound Healing | 2010 |